Kombiglyze
Pricing Report NDC 0003-4223-11

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Kombiglyze Xr (NDC 0003-4223-11) is $12.34805 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 22, 2017.

As a provided by E.r. Squibb & Sons, L.l.c., this medication is distributed in a 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$12.34805
Per EA

Effective Date
Feb 22, 2017
Billable Units
30 EA
Estimated Package Price
$370.44
Data Status
As of Mar 29, 2017
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2013, the NADAC wholesale price for (NDC ) has moved within a range of $8.36796 to $12.48306 per EA. Over this 3 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$8.3680 - $12.4831
Market Volatility
49.18% Variance
Latest Trend
1.08%
Date Unit Price Unit Source Method Rate
Feb 22, 2017 $12.34805 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 22, 2017 $12.34805 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2017 $12.48306 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2017 $12.48306 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Sep 21, 2016 $11.77648 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 21, 2016 $11.77648 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Dec 01, 2015 $11.76459 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Dec 01, 2015 $11.76459 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Oct 21, 2015 $10.51997 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 21, 2015 $10.51997 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2015 $10.52803 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2015 $10.52803 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2015 $10.52803 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Aug 08, 2014 $9.57956 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Aug 08, 2014 $9.57956 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2014 $9.03740 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2014 $9.03740 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Aug 15, 2013 $8.36796 EAC/I - Chain or Independent PharmacyCode 2B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026